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Background
Under PPTCT, babies born to sero-positive mothers
were followed up and tested at 18 months of age. Under
Early Infant Diagnosis (EID) program, HIV exposed
babies are subjected to HIV-1 DNA PCR on DBS and
whole blood as early as 6 weeks of age followed by
initiation of ART.
Methods
Infants born to HIV positive mothers were tested
according to NACO guidelines. Infants <6 months of
age (n=136) were tested by DBS HIV-1 DNA PCR; DBS
positive were confirmed by whole blood PCR. Infants 6
to 18 months (n=68) were tested by antibody test and if
positive were confirmed by DBS HIV-1 DNA PCR.
Detailed history including type of delivery, Single Dose
Nevirapine (SDN) and breast feeding was taken.
Results
The HIV transmission rate was 11.28% (23/204); 13
infants <6 months of age and 10 infants ≥6 months of
age. In infants <6 months of age, who did not receive
SDN the positivity was 38.46% (5/13) whereas in those
who received SDN it was 6.5% (8/123), [p=0.0012]. In
infants ≥6 months the positivity rate was significantly
higher in breast fed 60% (6/10) as compared to non
breast fed 6.9% (4/58),[p=0.0001]. 60.9% (14/23) infants
were delivered at home and did not receive SDN.
Conclusion
In resource limited settings, SDN given to mother in
labor is a good option.. Mothers intending to continue
breast feeding should be provided extended ART. EID
and prompt ART institution ensures favourable out-
comes in HIV exposed infants.
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